Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

Mitochondrial Disease (MELAS Syndrome) Discovered at the Start of Pregnancy in a Patient with Advanced CKD: A Clinical and Ethical Challenge.

Santoro D, Di Bella G, Toscano A, Musumeci O, Buemi M, Piccoli GB.

J Clin Med. 2019 Mar 4;8(3). pii: E303. doi: 10.3390/jcm8030303.

2.

Correction to Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments.

Ferro S, Deri B, Germanò MP, Gitto R, Ielo L, Buemi MR, Certo G, Vittorio S, Rapisarda A, Pazy Y, Fishman A, De Luca L.

J Med Chem. 2019 Feb 14;62(3):1697. doi: 10.1021/acs.jmedchem.9b00105. Epub 2019 Jan 30. No abstract available.

PMID:
30698018
3.

Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety.

Buemi MR, Di Fiore A, De Luca L, Angeli A, Mancuso F, Ferro S, Monti SM, Buonanno M, Russo E, De Sarro G, De Simone G, Supuran CT, Gitto R.

Eur J Med Chem. 2019 Feb 1;163:443-452. doi: 10.1016/j.ejmech.2018.11.073. Epub 2018 Dec 1.

PMID:
30530195
4.

Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.

Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D.

Expert Opin Investig Drugs. 2018 Nov;27(11):839-879. doi: 10.1080/13543784.2018.1540587. Epub 2018 Oct 30. Review.

PMID:
30360670
5.

Graphene Quantum Dots Based Systems As HIV Inhibitors.

Iannazzo D, Pistone A, Ferro S, De Luca L, Monforte AM, Romeo R, Buemi MR, Pannecouque C.

Bioconjug Chem. 2018 Sep 19;29(9):3084-3093. doi: 10.1021/acs.bioconjchem.8b00448. Epub 2018 Aug 22.

PMID:
30106563
6.

Erythropoiesis and chronic kidney disease-related anemia: From physiology to new therapeutic advancements.

Cernaro V, Coppolino G, Visconti L, Rivoli L, Lacquaniti A, Santoro D, Buemi A, Loddo S, Buemi M.

Med Res Rev. 2019 Mar;39(2):427-460. doi: 10.1002/med.21527. Epub 2018 Aug 6. Review.

PMID:
30084153
7.

Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening.

Ferro S, Gitto R, Buemi MR, Karamanou S, Stevaert A, Naesens L, De Luca L.

Bioorg Med Chem. 2018 Aug 15;26(15):4544-4550. doi: 10.1016/j.bmc.2018.07.046. Epub 2018 Jul 27.

PMID:
30082105
8.

Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis.

Cernaro V, Tripepi G, Visconti L, Lacquaniti A, Montalto G, Romeo A, Cimadoro D, Costantino G, Torre F, Santoro D, Buemi M; Workgroup of the Sicilian Registry of Nephrology, Dialysis and Transplantation.

Ther Apher Dial. 2018 Oct;22(5):457-468. doi: 10.1111/1744-9987.12684. Epub 2018 Jul 10.

PMID:
29992748
9.

Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis.

De Luca L, Ferro S, Buemi MR, Monforte AM, Gitto R, Schirmeister T, Maes L, Rescifina A, Micale N.

Chem Biol Drug Des. 2018 Sep;92(3):1585-1596. doi: 10.1111/cbdd.13326. Epub 2018 May 31.

PMID:
29729080
10.

Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments.

Ferro S, Deri B, Germanò MP, Gitto R, Ielo L, Buemi MR, Certo G, Vittorio S, Rapisarda A, Pazy Y, Fishman A, De Luca L.

J Med Chem. 2018 May 10;61(9):3908-3917. doi: 10.1021/acs.jmedchem.7b01745. Epub 2018 Apr 20. Erratum in: J Med Chem. 2019 Feb 14;62(3):1697.

PMID:
29634898
11.

C3 glomerulopathy in cystic fibrosis: a case report.

Santoro D, Siligato R, Vadalà C, Lucanto M, Cristadoro S, Conti G, Buemi M, Costa S, Sabadini E, Magazzù G.

BMC Nephrol. 2018 Mar 28;19(1):73. doi: 10.1186/s12882-018-0880-y.

12.

Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains.

Monforte AM, De Luca L, Buemi MR, Agharbaoui FE, Pannecouque C, Ferro S.

Bioorg Med Chem. 2018 Feb 1;26(3):661-674. doi: 10.1016/j.bmc.2017.12.033. Epub 2017 Dec 24.

PMID:
29291935
13.

[Long-term outcome of renal function in women with preeclampia and pregestational diabetes].

Vadalà C, Cernaro V, Siligato R, Granese R, Laganà AS, Buemi M, Santoro D.

G Ital Nefrol. 2017 Dec 5;34(Nov-Dec). pii: 2017-vol6. Review. Italian.

PMID:
29207220
14.

Beneficial effects of oral pure caffeine on oxidative stress.

Metro D, Cernaro V, Santoro D, Papa M, Buemi M, Benvenga S, Manasseri L.

J Clin Transl Endocrinol. 2017 Oct 13;10:22-27. doi: 10.1016/j.jcte.2017.10.001. eCollection 2017 Dec.

15.

Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.

De Luca L, Mancuso F, Ferro S, Buemi MR, Angeli A, Del Prete S, Capasso C, Supuran CT, Gitto R.

Eur J Med Chem. 2018 Jan 1;143:276-282. doi: 10.1016/j.ejmech.2017.11.061. Epub 2017 Nov 23.

PMID:
29197732
16.

The Myth of Water and Salt: From Aquaretics to Tenapanor.

Visconti L, Cernaro V, Calimeri S, Lacquaniti A, De Gregorio F, Ricciardi CA, Lacava V, Santoro D, Buemi M.

J Ren Nutr. 2018 Mar;28(2):73-82. doi: 10.1053/j.jrn.2017.06.005. Epub 2017 Nov 14. Review.

PMID:
29146141
17.

Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis.

Pisano A, Cernaro V, Gembillo G, D'Arrigo G, Buemi M, Bolignano D.

Int J Mol Sci. 2017 Oct 31;18(11). pii: E2283. doi: 10.3390/ijms18112283. Review.

18.

Cystic Fibrosis: A Risk Condition for Renal Disease.

Santoro D, Postorino A, Lucanto C, Costa S, Cristadoro S, Pellegrino S, Conti G, Buemi M, Magazzù G, Bellinghieri G.

J Ren Nutr. 2017 Nov;27(6):470-473. doi: 10.1053/j.jrn.2017.05.006.

PMID:
29056168
19.

The relationship between coping, emotion regulation, and quality of life of patients on dialysis.

Barberis N, Cernaro V, Costa S, Montalto G, Lucisano S, Larcan R, Buemi M.

Int J Psychiatry Med. 2017 Mar;52(2):111-123. doi: 10.1177/0091217417720893.

PMID:
28792286
20.

[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease].

Visconti L, Cernaro V, Ardissino G, Sgarbanti M, Ferrara D, Visconti G, Santoro D, Buemi M.

G Ital Nefrol. 2017 Apr;34(2):74-81. Italian.

PMID:
28682564
21.

Autoimmune Thyroiditis and Glomerulopathies.

Santoro D, Vadalà C, Siligato R, Buemi M, Benvenga S.

Front Endocrinol (Lausanne). 2017 Jun 2;8:119. doi: 10.3389/fendo.2017.00119. eCollection 2017. Review.

22.

Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study.

Cernaro V, Medici MA, Bianco F, Santoro D, Lacquaniti A, Romeo A, Lucisano S, Buemi A, Buemi M.

Clin Exp Pharmacol Physiol. 2017 Oct;44(10):1069-1071. doi: 10.1111/1440-1681.12798. Epub 2017 Aug 24.

PMID:
28613403
23.

Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis.

Bolignano D, Cernaro V, Gembillo G, Baggetta R, Buemi M, D'Arrigo G.

PLoS One. 2017 Jun 1;12(6):e0178699. doi: 10.1371/journal.pone.0178699. eCollection 2017. Review.

24.

Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors.

Ferro S, Buemi MR, De Luca L, Agharbaoui FE, Pannecouque C, Monforte AM.

Bioorg Med Chem. 2017 Jul 15;25(14):3861-3870. doi: 10.1016/j.bmc.2017.05.040. Epub 2017 May 19.

PMID:
28559060
25.

Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides.

Bruno E, Buemi MR, Di Fiore A, De Luca L, Ferro S, Angeli A, Cirilli R, Sadutto D, Alterio V, Monti SM, Supuran CT, De Simone G, Gitto R.

J Med Chem. 2017 May 25;60(10):4316-4326. doi: 10.1021/acs.jmedchem.7b00264. Epub 2017 May 9.

PMID:
28453941
26.

Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study.

Cernaro V, Lucisano S, Canale V, Bruzzese A, Caccamo D, Costantino G, Buemi M, Santoro D.

J Nephrol. 2018 Jun;31(3):429-433. doi: 10.1007/s40620-017-0393-y. Epub 2017 Apr 11.

PMID:
28401422
27.

Novel avenues for treating diabetic nephropathy: new investigational drugs.

Lacava V, Pellicanò V, Ferrajolo C, Cernaro V, Visconti L, Conti G, Buemi M, Santoro D.

Expert Opin Investig Drugs. 2017 Apr;26(4):445-462. doi: 10.1080/13543784.2017.1293039. Epub 2017 Feb 17. Review.

PMID:
28277032
28.

Decreased Endothelial Progenitor Cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis.

Laganà AS, Giordano D, Loddo S, Zoccali G, Vitale SG, Santamaria A, Buemi M, D'Anna R.

Arch Gynecol Obstet. 2017 Apr;295(4):867-872. doi: 10.1007/s00404-017-4296-x. Epub 2017 Feb 28.

PMID:
28243732
29.

Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis.

Giordano D, Loddo S, Laganà AS, Coppolino G, Zoccali G, Di Benedetto A, Santamaria A, Buemi M, D'Anna R.

J Matern Fetal Neonatal Med. 2018 Jan;31(2):258-260. doi: 10.1080/14767058.2016.1277703. Epub 2017 Jan 23.

PMID:
28110587
30.

Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma.

Atteritano M, Santoro D, Corallo G, Visalli E, Buemi M, Catalano A, Lasco A, Bitto A, Squadrito F.

Int J Mol Sci. 2016 Dec 14;17(12). pii: E2103.

31.

Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors.

Ferro S, De Luca L, Germanò MP, Buemi MR, Ielo L, Certo G, Kanteev M, Fishman A, Rapisarda A, Gitto R.

Eur J Med Chem. 2017 Jan 5;125:992-1001. doi: 10.1016/j.ejmech.2016.10.030. Epub 2016 Oct 18.

PMID:
27810600
32.

Metformin-related lactic acidosis: is it a myth or an underestimated reality?

Visconti L, Cernaro V, Ferrara D, Costantino G, Aloisi C, Amico L, Chirico V, Santoro D, Noto A, David A, Buemi M, Lacquaniti A.

Ren Fail. 2016 Oct;38(9):1560-1565. Epub 2016 Aug 10. Review.

PMID:
27686366
33.

High mobility group box 1 and tumor growth factor β: useful biomarkers in pediatric patients receiving peritoneal dialysis.

Chimenz R, Lacquaniti A, Colavita L, Chirico V, Fede C, Buemi M, Fede C.

Ren Fail. 2016 Oct;38(9):1370-1376. Epub 2016 Aug 8.

PMID:
27499050
34.

Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.

Atteritano M, Di Mauro E, Canale V, Bruzzese AM, Ricciardi CA, Cernaro V, Lacquaniti A, Buemi M, Santoro D.

Osteoporos Int. 2017 Feb;28(2):577-584. doi: 10.1007/s00198-016-3770-9. Epub 2016 Sep 28.

PMID:
27682249
35.

Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression.

Cernaro V, Sfacteria A, Rifici C, Macrì F, Maricchiolo G, Lacquaniti A, Ricciardi CA, Buemi A, Costantino G, Santoro D, Buemi M.

J Nephrol. 2017 Jun;30(3):385-391. doi: 10.1007/s40620-016-0353-y. Epub 2016 Sep 27.

PMID:
27679401
36.

Rational Design, Synthesis and Evaluation of Coumarin Derivatives as Protein-protein Interaction Inhibitors.

De Luca L, Agharbaoui FE, Gitto R, Buemi MR, Christ F, Debyser Z, Ferro S.

Mol Inform. 2016 Sep;35(8-9):460-73. doi: 10.1002/minf.201501034. Epub 2016 Jul 25.

PMID:
27546050
37.

Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease.

Visconti L, Benvenga S, Lacquaniti A, Cernaro V, Bruzzese A, Conti G, Buemi M, Santoro D.

J Clin Transl Endocrinol. 2016 Aug 20;6:8-14. doi: 10.1016/j.jcte.2016.08.002. eCollection 2016 Dec. Review.

38.

Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase.

Agharbaoui FE, Hoyte AC, Ferro S, Gitto R, Buemi MR, Fuchs JR, Kvaratskhelia M, De Luca L.

Eur J Med Chem. 2016 Nov 10;123:673-683. doi: 10.1016/j.ejmech.2016.07.077. Epub 2016 Aug 3.

39.

3 Tesla-Diffusion Tensor Imaging in Autosomal Dominant Polycystic Kidney Disease: The Nephrologist's Point of View.

Lupica R, Mormina E, Lacquaniti A, Trimboli D, Bianchimano B, Marino S, Bramanti P, Longo M, Buemi M, Granata F.

Nephron. 2016;134(2):73-80. Epub 2016 Aug 10.

PMID:
27504997
40.

Renal biopsy: Still a landmark for the nephrologist.

Visconti L, Cernaro V, Ricciardi CA, Lacava V, Pellicanò V, Lacquaniti A, Buemi M, Santoro D.

World J Nephrol. 2016 Jul 6;5(4):321-7. doi: 10.5527/wjn.v5.i4.321. Review.

41.

Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease.

Santoro D, Pellicanò V, Cernaro V, Lacava V, Lacquaniti A, Atteritano M, Buemi M.

Curr Med Chem. 2016;23(17):1698-707. Review.

PMID:
27048340
42.

Sclerostin levels in uremic patients: a link between bone and vascular disease.

Bruzzese A, Lacquaniti A, Cernaro V, Ricciardi CA, Loddo S, Romeo A, Montalto G, Costantino G, Torre F, Pettinato G, Salamone I, Aloisi C, Santoro D, Buemi M.

Ren Fail. 2016 Jun;38(5):759-64. doi: 10.3109/0886022X.2016.1160207. Epub 2016 Mar 22.

PMID:
27001371
43.

Kidney-lung connections in acute and chronic diseases: current perspectives.

Visconti L, Santoro D, Cernaro V, Buemi M, Lacquaniti A.

J Nephrol. 2016 Jun;29(3):341-348. doi: 10.1007/s40620-016-0276-7. Epub 2016 Mar 3. Review.

PMID:
26940339
44.

In Vivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents.

Bruno E, Buemi MR, De Luca L, Ferro S, Monforte AM, Supuran CT, Vullo D, De Sarro G, Russo E, Gitto R.

ChemMedChem. 2016 Aug 19;11(16):1812-8. doi: 10.1002/cmdc.201500596. Epub 2016 Feb 24.

PMID:
26915563
45.

The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933).

Ricciardi CA, Ricciardi E, Visconti L, Lacquaniti A, Savica V, Santoro D, Buemi M, Ricciardi B.

G Ital Nefrol. 2016 Feb;33 Suppl 66:33.S66.24.

46.

The management of kidney stones as suggested by Goeury-Duvivier.

Bellinghieri G, Satta E, Savica V, Gembillo G, Salvo A, Buemi M, Santoro D.

G Ital Nefrol. 2016 Feb;33 Suppl 66:33.S66.20.

47.

Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit.

Buemi MR, De Luca L, Ferro S, Russo E, De Sarro G, Gitto R.

Bioorg Med Chem. 2016 Apr 1;24(7):1513-9. doi: 10.1016/j.bmc.2016.02.021. Epub 2016 Feb 15.

PMID:
26912202
48.

Delayed graft function and chronic allograft nephropathy: diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin.

Lacquaniti A, Caccamo C, Salis P, Chirico V, Buemi A, Cernaro V, Noto A, Pettinato G, Santoro D, Bertani T, Buemi M, David A.

Biomarkers. 2016;21(4):371-8. doi: 10.3109/1354750X.2016.1141991. Epub 2016 Feb 22.

PMID:
26900638
49.

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide.

Cernaro V, Santoro D, Lacquaniti A, Costantino G, Visconti L, Buemi A, Buemi M.

Int J Nephrol Renovasc Dis. 2016 Feb 2;9:11-9. doi: 10.2147/IJNRD.S78040. eCollection 2016. Review.

50.

[DPP-4 inhibitors in nephropatics].

Bruzzese A, Pasquale M, Aloisi C, Costantino G, Buemi M.

G Ital Nefrol. 2015 Dec;35(Suppl 71). pii: 2018-supp71. Italian.

PMID:
29710442

Supplemental Content

Support Center